Protocol A022102, A Randomized Phase III Trial of mFOLFIRINOX +/- Nivolumab vs. FOLFOX +/- Nivolumab for First-line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma (NCT05677490)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
Principal Investigator
![Photograph of Lynn Mathew](https://researchstudies.cuanschutz.edu/Content/images/investigators/no-photo.jpg)
Lynn Mathew
Study ID
Protocol Number: 23-1072
More information available at ClinicalTrials.gov: NCT05677490
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers